Nanordica Medical was recognized by SmartTRAK, a leading market intelligence platform in wound care, as one of four advanced wound dressing companies to watch. In its Outlook, SmartTRAK highlights the design of Nanordica’s Premotiv® dressing, developed to simultaneously prevent infection and support natural wound healing while addressing the Silver Paradox in antimicrobial wound care.

As one of the largest clinical trials in the field nears completion, Nanordica Medical is preparing to bring the Premotiv® dressing to patients in Europe in 2026, followed by entry into the US market in 2027.

Read full article by SmartTRAK: https://blog.smarttrak.com/attacking-bioburden-and-infection-four-advanced-dressing-companies-to-watch-in-2026